PPS-Exempt Cancer Hospital Quality Reporting (PCHQR) Program
Clinical Process/Oncology Care Measures
Paper Submission for FY2020 and Subsequent Years
(NQF 0382) Oncology: Radiation Dose Limits to Normal Tissues
Q1 Q2 Q3 Q4
Patients
who had documentation in medical record that radiation dose limits
to normal tissues were established prior to the initiation of a
course of 3D conformal radiation for a minimum of two tissues
DENOMINATOR
All
patients, regardless of age, with a diagnosis of pancreatic, breast,
rectal, or lung cancer receiving 3D conformal radiation therapy
(NQF 0383) Oncology: Plan of Care for Pain – Medical Oncology and Radiation Oncology
Q1 Q2 Q3 Q4
NUMERATOR
Patient
visits that included a documented plan of care to address pain. Documented
plan of care may include: use of opioids, nonopioids analgesics,
psychological support, patient and/or family education, referral to
a pain clinic, or reassessment of pain at an appropriate time
interval
DENOMINATOR
All
selected surgical patients with a catheter in place postoperatively
(NQF 0384) Oncology: Pain Intensity Quantified- Medical Oncology and Radiation Oncology
Q1 Q2 Q3 Q4
NUMERATOR
Patient
visits in which pain intensity is quantified. Pain
intensity should be quantified using a standard instrument, such as
a 0-10 numerical rating scale, a categorical scale, or the pictorial
scale
DENOMINATOR
All
visits for patients, regardless of age, with a diagnosis of cancer
currently receiving chemotherapy or radiation therapy
(NQF 0389) Prostate Cancer: Avoidance of Overuse Measure- Bone Scan for Staging Low-Risk Patients
Q1 Q2 Q3 Q4
Patients
who did not have a bone scan performed any time since diagnosis of
prostate surgery
All
patients, regardless of age, with a diagnosis of prostate cancer, at
low risk of recurrence, receiving interstitial prostate
brachytherapy, OR external beam radiotherapy to the prostate, OR
radical prostatectomy, OR cryotherapy
(NQF 0390) Prostate Cancer: Adjuvant Hormonal Therapy for High-Risk Patients
Q1 Q2 Q3 Q4
Patients
who were prescribed adjuvant hormonal therapy (GnRH)
[gonadotropin-releasing hormone] agonist or antagonist)
All
patients, regardless of age, with a diagnosis of prostate cancer, at
high risk of recurrence, receiving external beam radiotherapy to the
prostate
(*) indicates required for providers participating in the PPS-Exempt Cancer Hospital Quality Reporting Program.
* Facility Name:
* CEO Signature: * Date:
* CEO Email Address:
Complete and submit this form via email to: PCHQualityReporting@hcqis.org.
Following receipt of the request form, an email acknowledgement will be sent confirming the form has been received.
PRA
Disclosure Statement
According to the Paperwork Reduction Act of
1995, no persons are required to respond to a collection of
information unless it displays a valid OMB control number. The valid
OMB control number for this information collection is 0938-1175 and
expires XX/XX/XXXX. The time required to complete this information
collection is estimated to average 10 minutes per response, including
the time to review instructions, search existing data resources,
gather the data needed, and complete and review the information
collection. If you have comments concerning the accuracy of the time
estimate(s) or suggestions for improving this form, please write to:
CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer,
Mail Stop C4-26-05, Baltimore, Maryland 21244-1850. *****CMS
Disclaimer*****Please
do not send applications, claims, payments, medical records or any
documents containing sensitive information to the PRA Reports
Clearance Office. Please note that any correspondence not pertaining
to the information collection burden approved under the associated
OMB control number listed on this form will not be reviewed,
forwarded, or retained. If you have questions or concerns regarding
where to submit your documents, please contact James Poyer at (410)
786-2261.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | PCHQR Clinical Process/Oncology Care Measures |
Subject | PCHQR Clinical Process/Oncology Care Measures |
Author | CMS |
File Modified | 0000-00-00 |
File Created | 2021-01-22 |